Search 10,505 records for:

Display

Collections

Format

Fulltext Search

Off On

Publication Type

Year

Topic

Show more

Name

Collection

Fulltext Search

Off On

Publication Type

Year

Topic

Show more

Name

Collection

OHSU 4 records found Search took 0.39 seconds. 
1.
2.
For patients receiving Lu-DOTATATE therapy (four cycles every 8 weeks) for treatment of neuroendocrine tumors: does timing of laboratory assessment between treatment cycl [...]
2023 | Capstone |
3.
Lutetium-177 vipivotide tetraxetan (Lu-177 PSMA-617) therapy is an effective treatment for patients with metastatic prostate cancer, although with potential adverse effec [...]
2024-06-14 | Thesis |
4.
Lutathera is a radiopharmaceutical used to treat gastroenteropancreatic-neuroendocrine tumors(GEP-NETs) in adults that are positive for hormone receptor somatostatin. The [...]
2022 | Thesis |

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.